Jing Xiang
State Key Lab Of Rice Biology
Hangzhou, 311400, China
Hangzhou, 311400, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Bronchial Artery Chemoembolization (BACE) Combined with PD-1 Blockade Versus Chemotherapy Combined with PD-1 Blockade for Non-Small Cell Lung Cancer in Older Adults.
Journal: Clinical interventions in aging
Published: May 09, 2026
Co-occurrence of carbapenem and tigecycline resistance genes in ST1545 Klebsiella pneumoniae clinical isolates from China.
Journal: International journal of antimicrobial agents
Published: January 26, 2026
Mechanisms and recent advances in non-coding RNAs and RNA modifications in antiplatelet drug resistance.
Journal: Frontiers in genetics
Published: April 25, 2025
Efficacy and Safety of Dupilumab in Treating Intrinsic and Extrinsic Atopic Dermatitis in Older Patients With and Without Atopic Comorbidities: A Retrospective Study.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: February 12, 2025
Metagenomic analysis reveals the abundance changes of bacterial communities and antibiotic resistance genes in the influent and effluent of hospital wastewater.
Journal: PloS one
Published: October 23, 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 27, 2024
Comparative Transcriptome Combined with Morphophysiological Analyses Revealed Carotenoid Biosynthesis for Differential Chilling Tolerance in Two Contrasting Rice (Oryza sativa L.) Genotypes.
Journal: Rice (New York, N.Y.)
Published: September 07, 2023
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiency.
Journal: Translational oncology
Published: April 06, 2023
Clinical outcomes of immune checkpoint inhibitors to treat non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.
Journal: BMC pulmonary medicine
Published: November 08, 2022
Last Updated: 09/26/2026